The latest research report by Emergen Research, named ‘Global In-Vitro Diagnostics Market - Forecast to 2028’, entails a comprehensive review of the global In-Vitro Diagnostics market’s present and future trends. Rising need for surgical procedures is expected to fuel market growth. Increased awareness about personalized medicine and adoption of point-of-care testing is also contributing to in-vitro diagnostics market growth.
Advancements in technology has led to increased availability of over-the-counter tests for better treatment. This adds significant value to medical diagnosis and treatment processes, thus improving service and patient experience. Another factor driving market growth is development of Next Generation Sequencing (NGS). NGS along with data analysis algorithms allow researchers and clinicians to uncover cancer pathways, hidden aspects of antibiotic resistance, and rare chronic diseases. It also offers speed and accuracy and reduces time to diagnosis.
To get a sample copy of the Global In-Vitro Diagnostics Market report, visit @ https://www.emergenresearch.com/request-sample/70
Some major companies operating in the market include Siemens Healthineers, Roche Diagnostics, Danaher Corporation, bioMérieux, Abbott Laboratories, DiaSorin, Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, QIAGEN, and Sysmex Corporation.
- The report closely studies the growth trajectory of the global In-Vitro Diagnostics market. It brings to light the global dominance of the leading regional segments, including North America, Asia Pacific, Europe, Latin America, and the Middle East Africa.
- The study elaborates on the crucial information pertaining to the regional market share. It simultaneously focuses on the significant details about the growth patterns of each regional market.
Market players are taking various initiatives to drive the growth of the market. For instance, in April 2021, Avacta, developer of cancer diagnostics and therapies based on its precision and Afirmer platforms, have entered a license agreement with Biokit to integrate Affirmer’s reagents into a Biokit in-vitro diagnostic (IVD) product. The agreement allows extensive evaluation by Biokit of certain Affirmer reagents for detection of a key analytic.
To learn more details about the Global In-Vitro Diagnostics Market report, visit @ https://www.emergenresearch.com/industry-report/in-vitro-diagnostics-market
Unfolding the prime factors prompting global market growth:
- The study offers an in-depth analysis of the product outlook, which depicts the latest production growth trends and profit valuation. It further fragments the global In-Vitro Diagnostics market into a broad product spectrum.
- The study covers essential data related to these products’ application landscape, the demand for and market share held by each application type, and their growth rate analysis over the estimated period.
Emergen Research has segmented the global in-vitro diagnostics market on the basis of product, devices, application, technique, end-use, and region:
Product Outlook (Revenue, USD Billion; 2018–2028)
- Reagents Kits
- Instruments
- Fully Automated Instruments
- Semi-Automated Instruments
- Data Management Software
- Services
Devices Outlook (Revenue, USD Billion; 2018–2028)
- Reusable IVD Devices
- Disposable IVD Devices
Technique Outlook (Revenue, USD Billion; 2018–2028)
- Clinical Chemistry
- Basic Metabolic Panel
- Electrolyte Panel
- Liver Panel
- Lipid Profile
- Renal Profile
- Thyroid Function Panel
- Molecular Diagnostics
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Technology
- Microarray
- Hybridization
- DNA Sequencing Next-Generation Sequencing
- Other Molecular Diagnostics Technologies
To get a customization of the report, visit @ https://www.emergenresearch.com/request-for-customization/70
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyses consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
